Page last updated: 2024-11-01

nomifensine and Syndrome

nomifensine has been researched along with Syndrome in 3 studies

Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.

Syndrome: A characteristic symptom complex.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sandyk, R1
Guliamov, MG1
Cunha, UV1

Other Studies

3 other studies available for nomifensine and Syndrome

ArticleYear
Nomifensine-induced orofacial dyskinesia and Sydenham's chorea.
    The International journal of neuroscience, 1987, Volume: 35, Issue:1-2

    Topics: Chorea; Dyskinesia, Drug-Induced; Facial Muscles; Female; Humans; Middle Aged; Mouth; Nomifensine; S

1987
[Comparative evaluation of the therapeutic efficacy of the antidepressants adepren, linamiphen and emovit].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1986, Volume: 86, Issue:4

    Topics: Adjustment Disorders; Adolescent; Adult; Aminoquinolines; Antidepressive Agents; Bipolar Disorder; D

1986
Antidepressants: their uses in nonpsychiatric disorders of aging.
    Geriatrics, 1986, Volume: 41, Issue:10

    Topics: Affective Symptoms; Aged; Antidepressive Agents; Chronic Disease; Colonic Diseases, Functional; Depr

1986